世界のレーバー先天性黒内障（LCA）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Leber Congenital Amaurosis (LCA) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4418
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、レーバー先天性黒内障（LCA）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（乳幼児タイプ、小児タイプ）、用途別市場規模（病院、眼科クリニック、医療研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・レーバー先天性黒内障（LCA）の市場動向
・企業の競争状況、市場シェア
・レーバー先天性黒内障（LCA）の種類別市場規模と予測2016-2027（乳幼児タイプ、小児タイプ）
・レーバー先天性黒内障（LCA）の用途別市場規模と予測2016-2027（病院、眼科クリニック、医療研究所、その他）
・レーバー先天性黒内障（LCA）の北米市場規模2016-2027（アメリカ、カナダ）
・レーバー先天性黒内障（LCA）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・レーバー先天性黒内障（LCA）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・レーバー先天性黒内障（LCA）の中南米市場規模2016-2027（メキシコ、ブラジル）
・レーバー先天性黒内障（LCA）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AmpliPhi Biosciences、Editas Medicine、Novelion Therapeutics、ProQR Therapeutics、Spark Therapeutics）
・結論

Leber congenital amaurosis is a kind of autosomal recessive genetic disease, it is the main genetic disease that brings about children blindness, accompany mental nerve symptom, wait like intellectual inferior, hearing obstacle, epilepsy, conus cornea can happen when some age is older or spherical cornea.

Market Analysis and Insights: Global Leber Congenital Amaurosis (LCA) Market
The global Leber Congenital Amaurosis (LCA) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leber Congenital Amaurosis (LCA) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leber Congenital Amaurosis (LCA) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leber Congenital Amaurosis (LCA) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leber Congenital Amaurosis (LCA) market.

Global Leber Congenital Amaurosis (LCA) Scope and Market Size
Leber Congenital Amaurosis (LCA) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leber Congenital Amaurosis (LCA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Infantile Type
Juvenile Type

Segment by Application
Hospitals
Eye Clinics
Medical Research Institute
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AmpliPhi Biosciences
Editas Medicine
Novelion Therapeutics
ProQR Therapeutics
Spark Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Infantile Type
1.2.3 Juvenile Type
1.3 Market by Application
1.3.1 Global Leber Congenital Amaurosis (LCA) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Medical Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Leber Congenital Amaurosis (LCA) Market Perspective (2016-2027)
2.2 Leber Congenital Amaurosis (LCA) Growth Trends by Regions
2.2.1 Leber Congenital Amaurosis (LCA) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leber Congenital Amaurosis (LCA) Historic Market Share by Regions (2016-2021)
2.2.3 Leber Congenital Amaurosis (LCA) Forecasted Market Size by Regions (2022-2027)
2.3 Leber Congenital Amaurosis (LCA) Industry Dynamic
2.3.1 Leber Congenital Amaurosis (LCA) Market Trends
2.3.2 Leber Congenital Amaurosis (LCA) Market Drivers
2.3.3 Leber Congenital Amaurosis (LCA) Market Challenges
2.3.4 Leber Congenital Amaurosis (LCA) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Leber Congenital Amaurosis (LCA) Players by Revenue
3.1.1 Global Top Leber Congenital Amaurosis (LCA) Players by Revenue (2016-2021)
3.1.2 Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Players (2016-2021)
3.2 Global Leber Congenital Amaurosis (LCA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leber Congenital Amaurosis (LCA) Revenue
3.4 Global Leber Congenital Amaurosis (LCA) Market Concentration Ratio
3.4.1 Global Leber Congenital Amaurosis (LCA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leber Congenital Amaurosis (LCA) Revenue in 2020
3.5 Leber Congenital Amaurosis (LCA) Key Players Head office and Area Served
3.6 Key Players Leber Congenital Amaurosis (LCA) Product Solution and Service
3.7 Date of Enter into Leber Congenital Amaurosis (LCA) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Leber Congenital Amaurosis (LCA) Breakdown Data by Type
4.1 Global Leber Congenital Amaurosis (LCA) Historic Market Size by Type (2016-2021)
4.2 Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Type (2022-2027)

5 Leber Congenital Amaurosis (LCA) Breakdown Data by Application
5.1 Global Leber Congenital Amaurosis (LCA) Historic Market Size by Application (2016-2021)
5.2 Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Leber Congenital Amaurosis (LCA) Market Size (2016-2027)
6.2 North America Leber Congenital Amaurosis (LCA) Market Size by Type
6.2.1 North America Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021)
6.2.2 North America Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027)
6.2.3 North America Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2027)
6.3 North America Leber Congenital Amaurosis (LCA) Market Size by Application
6.3.1 North America Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021)
6.3.2 North America Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027)
6.3.3 North America Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2027)
6.4 North America Leber Congenital Amaurosis (LCA) Market Size by Country
6.4.1 North America Leber Congenital Amaurosis (LCA) Market Size by Country (2016-2021)
6.4.2 North America Leber Congenital Amaurosis (LCA) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Leber Congenital Amaurosis (LCA) Market Size (2016-2027)
7.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Type
7.2.1 Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021)
7.2.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027)
7.2.3 Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2027)
7.3 Europe Leber Congenital Amaurosis (LCA) Market Size by Application
7.3.1 Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021)
7.3.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027)
7.3.3 Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2027)
7.4 Europe Leber Congenital Amaurosis (LCA) Market Size by Country
7.4.1 Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2016-2021)
7.4.2 Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size (2016-2027)
8.2 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Type
8.2.1 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2027)
8.3 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Application
8.3.1 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2027)
8.4 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Region
8.4.1 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Leber Congenital Amaurosis (LCA) Market Size (2016-2027)
9.2 Latin America Leber Congenital Amaurosis (LCA) Market Size by Type
9.2.1 Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021)
9.2.2 Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027)
9.2.3 Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2027)
9.3 Latin America Leber Congenital Amaurosis (LCA) Market Size by Application
9.3.1 Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021)
9.3.2 Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027)
9.3.3 Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2027)
9.4 Latin America Leber Congenital Amaurosis (LCA) Market Size by Country
9.4.1 Latin America Leber Congenital Amaurosis (LCA) Market Size by Country (2016-2021)
9.4.2 Latin America Leber Congenital Amaurosis (LCA) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size (2016-2027)
10.2 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type
10.2.1 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2027)
10.3 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application
10.3.1 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2027)
10.4 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Country
10.4.1 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AmpliPhi Biosciences
11.1.1 AmpliPhi Biosciences Company Details
11.1.2 AmpliPhi Biosciences Business Overview
11.1.3 AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Introduction
11.1.4 AmpliPhi Biosciences Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021)
11.1.5 AmpliPhi Biosciences Recent Development
11.2 Editas Medicine
11.2.1 Editas Medicine Company Details
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine Leber Congenital Amaurosis (LCA) Introduction
11.2.4 Editas Medicine Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021)
11.2.5 Editas Medicine Recent Development
11.3 Novelion Therapeutics
11.3.1 Novelion Therapeutics Company Details
11.3.2 Novelion Therapeutics Business Overview
11.3.3 Novelion Therapeutics Leber Congenital Amaurosis (LCA) Introduction
11.3.4 Novelion Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021)
11.3.5 Novelion Therapeutics Recent Development
11.4 ProQR Therapeutics
11.4.1 ProQR Therapeutics Company Details
11.4.2 ProQR Therapeutics Business Overview
11.4.3 ProQR Therapeutics Leber Congenital Amaurosis (LCA) Introduction
11.4.4 ProQR Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021)
11.4.5 ProQR Therapeutics Recent Development
11.5 Spark Therapeutics
11.5.1 Spark Therapeutics Company Details
11.5.2 Spark Therapeutics Business Overview
11.5.3 Spark Therapeutics Leber Congenital Amaurosis (LCA) Introduction
11.5.4 Spark Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021)
11.5.5 Spark Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Leber Congenital Amaurosis (LCA) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Infantile Type
Table 3. Key Players of Juvenile Type
Table 4. Global Leber Congenital Amaurosis (LCA) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Leber Congenital Amaurosis (LCA) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Leber Congenital Amaurosis (LCA) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Leber Congenital Amaurosis (LCA) Market Share by Regions (2016-2021)
Table 8. Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Leber Congenital Amaurosis (LCA) Market Share by Regions (2022-2027)
Table 10. Leber Congenital Amaurosis (LCA) Market Trends
Table 11. Leber Congenital Amaurosis (LCA) Market Drivers
Table 12. Leber Congenital Amaurosis (LCA) Market Challenges
Table 13. Leber Congenital Amaurosis (LCA) Market Restraints
Table 14. Global Leber Congenital Amaurosis (LCA) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Leber Congenital Amaurosis (LCA) Market Share by Players (2016-2021)
Table 16. Global Top Leber Congenital Amaurosis (LCA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leber Congenital Amaurosis (LCA) as of 2020)
Table 17. Ranking of Global Top Leber Congenital Amaurosis (LCA) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Leber Congenital Amaurosis (LCA) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Leber Congenital Amaurosis (LCA) Product Solution and Service
Table 21. Date of Enter into Leber Congenital Amaurosis (LCA) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Type (2016-2021)
Table 25. Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Leber Congenital Amaurosis (LCA) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Application (2016-2021)
Table 29. Global Leber Congenital Amaurosis (LCA) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Leber Congenital Amaurosis (LCA) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Leber Congenital Amaurosis (LCA) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Leber Congenital Amaurosis (LCA) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Leber Congenital Amaurosis (LCA) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Leber Congenital Amaurosis (LCA) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size by Country (2022-2027) & (US$ Million)
Table 61. AmpliPhi Biosciences Company Details
Table 62. AmpliPhi Biosciences Business Overview
Table 63. AmpliPhi Biosciences Leber Congenital Amaurosis (LCA) Product
Table 64. AmpliPhi Biosciences Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021) & (US$ Million)
Table 65. AmpliPhi Biosciences Recent Development
Table 66. Editas Medicine Company Details
Table 67. Editas Medicine Business Overview
Table 68. Editas Medicine Leber Congenital Amaurosis (LCA) Product
Table 69. Editas Medicine Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021) & (US$ Million)
Table 70. Editas Medicine Recent Development
Table 71. Novelion Therapeutics Company Details
Table 72. Novelion Therapeutics Business Overview
Table 73. Novelion Therapeutics Leber Congenital Amaurosis (LCA) Product
Table 74. Novelion Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021) & (US$ Million)
Table 75. Novelion Therapeutics Recent Development
Table 76. ProQR Therapeutics Company Details
Table 77. ProQR Therapeutics Business Overview
Table 78. ProQR Therapeutics Leber Congenital Amaurosis (LCA) Product
Table 79. ProQR Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021) & (US$ Million)
Table 80. ProQR Therapeutics Recent Development
Table 81. Spark Therapeutics Company Details
Table 82. Spark Therapeutics Business Overview
Table 83. Spark Therapeutics Leber Congenital Amaurosis (LCA) Product
Table 84. Spark Therapeutics Revenue in Leber Congenital Amaurosis (LCA) Business (2016-2021) & (US$ Million)
Table 85. Spark Therapeutics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leber Congenital Amaurosis (LCA) Market Share by Type: 2020 VS 2027
Figure 2. Infantile Type Features
Figure 3. Juvenile Type Features
Figure 4. Global Leber Congenital Amaurosis (LCA) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Eye Clinics Case Studies
Figure 7. Medical Research Institute Case Studies
Figure 8. Other Case Studies
Figure 9. Leber Congenital Amaurosis (LCA) Report Years Considered
Figure 10. Global Leber Congenital Amaurosis (LCA) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Leber Congenital Amaurosis (LCA) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Leber Congenital Amaurosis (LCA) Market Share by Regions: 2020 VS 2027
Figure 13. Global Leber Congenital Amaurosis (LCA) Market Share by Regions (2022-2027)
Figure 14. Global Leber Congenital Amaurosis (LCA) Market Share by Players in 2020
Figure 15. Global Top Leber Congenital Amaurosis (LCA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leber Congenital Amaurosis (LCA) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Leber Congenital Amaurosis (LCA) Revenue in 2020
Figure 17. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Type (2016-2021)
Figure 18. Global Leber Congenital Amaurosis (LCA) Revenue Market Share by Type (2022-2027)
Figure 19. North America Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Leber Congenital Amaurosis (LCA) Market Share by Type (2016-2027)
Figure 21. North America Leber Congenital Amaurosis (LCA) Market Share by Application (2016-2027)
Figure 22. North America Leber Congenital Amaurosis (LCA) Market Share by Country (2016-2027)
Figure 23. United States Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Leber Congenital Amaurosis (LCA) Market Share by Type (2016-2027)
Figure 27. Europe Leber Congenital Amaurosis (LCA) Market Share by Application (2016-2027)
Figure 28. Europe Leber Congenital Amaurosis (LCA) Market Share by Country (2016-2027)
Figure 29. Germany Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Leber Congenital Amaurosis (LCA) Market Share by Region (2016-2027)
Figure 39. China Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Leber Congenital Amaurosis (LCA) Market Share by Type (2016-2027)
Figure 47. Latin America Leber Congenital Amaurosis (LCA) Market Share by Application (2016-2027)
Figure 48. Latin America Leber Congenital Amaurosis (LCA) Market Share by Country (2016-2027)
Figure 49. Mexico Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Leber Congenital Amaurosis (LCA) Market Share by Country (2016-2027)
Figure 55. Turkey Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Leber Congenital Amaurosis (LCA) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AmpliPhi Biosciences Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2016-2021)
Figure 59. Editas Medicine Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2016-2021)
Figure 60. Novelion Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2016-2021)
Figure 61. ProQR Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2016-2021)
Figure 62. Spark Therapeutics Revenue Growth Rate in Leber Congenital Amaurosis (LCA) Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の糖鎖生物学（診断＆治療）市場規模・現状・予測（2021年-2027年）

Global Glycobiology (Diagnostics and Therapeutics) Market Size, Status and Forecast 2021-2027
QFJ1-3462 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、糖鎖生物学（診断＆治療）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の先天性インスリン過剰症市場規模・現状・予測（2021年-2027年）

Global Congenital Hyperinsulinism Market Size, Status and Forecast 2021-2027
QFJ1-4047 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、先天性インスリン過剰症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、医薬品、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年）

Global CDKL5 Deficiency Disorder (CDD) Market Size, Status and Forecast 2021-2027
QFJ1-3983 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、CDKL5欠乏症（CDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（従来型医薬品、新型医薬品）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のアンチセンスオリゴヌクレオチド(ASO)市場規模・現状・予測（2021年-2027年）

Global Antisense Oligonucleotides Market Size, Status and Forecast 2021-2027
QFJ1-3837 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、アンチセンスオリゴヌクレオチド(ASO)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RNAアンチセンスオリゴヌクレオチド、DNAアンチセンスオリゴヌクレオチド）、用途別市場規模（病院、診療所、その...

世界の遺伝性トランスサイレチンアミロイドーシス(HATTR)市場規模・現状・予測（2021年-2027年）

Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, Status and Forecast 2021-2027
QFJ1-4310 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、遺伝性トランスサイレチンアミロイドーシス(HATTR)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、皮下注射、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリ...

世界の先天性好中球減少症治療市場規模・現状・予測（2021年-2027年）

Global Congenital Neutropenia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5131 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、先天性好中球減少症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、顆粒球コロニー刺激因子（G-CSF）、抗真菌薬）、用途別市場規模（小売薬局、病院薬局、オンライン薬局、その他）、主要地域...

世界の先天性インスリン過剰症治療薬市場規模・現状・予測（2021年-2027年）

Global Congenital Hyperinsulinism Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5672 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、先天性インスリン過剰症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジアゾキシド、オクトレオチド、グルカゴン）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Medicinal Products (GTMP) Market Size, Status and Forecast 2021-2027
QFJ1-5750 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、遺伝子治療医薬品（GTMP）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のデジタル治療（DTx）市場規模・現状・予測（2021年-2027年）

Global Digital Therapeutic (DTx) Market Size, Status and Forecast 2021-2027
QFJ1-4134 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、デジタル治療（DTx）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ソフトウェア、サービス、ハードウェア）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の間質性肺疾患（ILD）市場規模・現状・予測（2021年-2027年）

Global Interstitial Lung Disease (ILD) Market Size, Status and Forecast 2021-2027
QFJ1-4382 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、間質性肺疾患（ILD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（間質性肺炎、特発性肺線維症、非特異性間質性肺炎、過敏性肺炎、特発性器質性肺炎、急性間質性肺炎、剥離性間質性肺炎、その他）、用途別市...

世界の先天性インスリン過剰症市場規模・現状・予測（2021年-2027年） Congenital hyperinsulinism (CHI) is a condition that causes individuals to have abnormally high levels of insulin, which is a hormone that helps control blood sugar levels. People with this condition have frequent occurrences of low blood sugar (hypoglycemia). In infants and young children, these oc…
世界の先天性好中球減少症治療市場規模・現状・予測（2021年-2027年） Congenital neutropenia occurs when an individual has low levels of neutrophils, a type of white blood cells. Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones such as the vertebrae, ribs, and pelvis. The congenital neutropenia treatment include antibiotics, an…
世界の先天性インスリン過剰症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Congenital Hyperinsulinism Treatment Drugs Market The global Congenital Hyperinsulinism Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
レーバー遺伝性視神経萎縮症薬のグローバル市場調査 2019年 The global Leber's Hereditary Optic Neuropathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Leber's Hereditary Optic Neuropathy Drug volume and value at global level, regional level and comp…
先天性心疾患オクルーダーのグローバル市場調査 2019年 The global Congenital Heart Disease Occluder market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Congenital Heart Disease Occluder volume and value at global level, regional level and company level. Fro…